Alternatives to Orgovyx If You Can't Fill Your Prescription

Orgovyx (relugolix) is a highly effective oral androgen deprivation therapy (ADT) for advanced prostate cancer. But specialty-only distribution, prior authorization hurdles, and insurance formulary restrictions sometimes make it difficult or impossible to fill promptly. If you're in that situation, this guide explains the most clinically comparable alternatives your oncologist or urologist may consider.

Important: Never switch or stop your ADT without discussing it with your prescribing physician. Androgen deprivation is a critical part of your cancer treatment, and any change requires medical oversight.

How Orgovyx Works (Quick Background)

Orgovyx is a GnRH (gonadotropin-releasing hormone) receptor antagonist. It competitively blocks GnRH receptors in the pituitary gland, rapidly reducing LH, FSH, and ultimately testosterone — without the testosterone "flare" that occurs with GnRH agonists. It achieved 96.7% sustained castration rates in the HERO Phase 3 trial and showed a 54% lower rate of major adverse cardiovascular events compared to leuprolide. Understanding this helps frame how its alternatives compare.

Alternative #1: Degarelix (Firmagon) — The Injectable GnRH Antagonist

Degarelix (Firmagon) is the most mechanistically similar alternative to Orgovyx. Like Orgovyx, it is a GnRH receptor antagonist — meaning it directly blocks GnRH receptors without causing an initial testosterone surge. It was FDA-approved in 2008 for advanced prostate cancer and has a long track record of clinical use.

Key difference: Degarelix is administered as a subcutaneous injection — two 120 mg injections (240 mg loading dose) on day 1, followed by monthly 80 mg injections. It is not an oral medication and requires monthly clinic visits. Injection-site reactions (pain, redness, swelling) are more common than with Orgovyx.

Degarelix is available at many standard oncology and urology practices and may be more readily accessible than Orgovyx for patients who can tolerate injections.

Alternative #2: Leuprolide (Lupron Depot, Eligard, Camcevi) — GnRH Agonist Injections

Leuprolide is the most widely used ADT in the United States and is available under several brand names including Lupron Depot, Eligard, and Camcevi. As a GnRH agonist, it works differently from Orgovyx — it initially stimulates the pituitary, then causes receptor downregulation leading to testosterone suppression. This process can cause a brief "testosterone flare" in the first 1-2 weeks of treatment, which can temporarily worsen symptoms in some patients with metastatic disease.

Key advantage: Leuprolide has extended-release injection formulations (1-month, 3-month, 4-month, 6-month) allowing less frequent dosing than daily oral Orgovyx. A generic version of leuprolide acetate is available, making it significantly less expensive. It is widely stocked at oncology clinics and standard pharmacies.

Key limitation: Leuprolide caused a higher rate of major cardiovascular events (6.2%) compared to Orgovyx (2.9%) in the HERO trial. Patients with a history of cardiovascular disease may be better candidates for a GnRH antagonist.

Alternative #3: Goserelin (Zoladex) — Monthly or Quarterly GnRH Agonist Implant

Goserelin (Zoladex) is a GnRH agonist available as a small subcutaneous implant injected into the abdomen every 1 or 3 months. Like leuprolide, it suppresses testosterone through pituitary desensitization, so it carries the same risk of initial testosterone flare. However, it has a well-established efficacy record and is widely covered by insurance for advanced prostate cancer.

Zoladex is administered by a healthcare professional and is billed through the medical benefit rather than pharmacy benefit, which may be relevant for some Medicare patients.

Alternative #4: Triptorelin (Trelstar) — Quarterly GnRH Agonist Injection

Triptorelin (Trelstar) is another GnRH agonist available as an intramuscular injection given every 1, 3, or 6 months. It works through the same mechanism as leuprolide and goserelin and is approved for advanced prostate cancer. Triptorelin is manufactured by a different company than AbbVie (which makes Lupron), providing an independent supply source that may be more accessible if supply chains for other agents are constrained.

How to Choose: A Quick Comparison

Prefer no injections? Orgovyx is the only oral option; if unavailable, discuss why with your doctor before switching.

History of heart disease? Orgovyx or degarelix (both GnRH antagonists) may be preferred over GnRH agonists due to lower cardiovascular event rates.

Cost is the barrier? Generic leuprolide is significantly less expensive than Orgovyx. Ask your doctor if it's clinically appropriate for your situation.

Symptomatic metastatic disease? Avoid initial testosterone flare — GnRH antagonists (Orgovyx or degarelix) are generally preferred.

Don't Give Up on Orgovyx — Try medfinder First

Before deciding to switch medications, it's worth confirming whether Orgovyx is truly unavailable near you or just requires additional steps to access. medfinder calls pharmacies on your behalf to find which specialty pharmacies can fill your Orgovyx prescription. Read our guide on how to find Orgovyx in stock near you before switching to an alternative.